<DOC>
	<DOCNO>NCT01657656</DOCNO>
	<brief_summary>Hypothesis That improve vitamin D status among TB patient speed pace bacteriological cure , enhance immune response TB infection</brief_summary>
	<brief_title>Vitamin D Supplementations Adjunct Anti-Tuberculosis Drugs Mongolia</brief_title>
	<detailed_description>Tuberculosis ( TB ) world 's large single cause death infection 30-year period 1990 2020 . More 95 % TB case , death due TB , occur develop country . Mongolia one country high tuberculosis burden Western Pacific region . In addition , vitamin D deficiency endemic Mongolia . We propose determine efficacy vitamin D supplement , adjunct multidrug therapy , enhance anti-microbial immune response TB , find could lead development short drug regimen , thus efficient effective TB treatment protocol . We propose conduct double blind , placebo control , randomize clinical trial test effect daily vitamin D supplementation ability subject control TB infection . The Primary Endpoint : The primary endpoint : time sputum culture conversion positive negative . The number day sputum conversion measure , intervention control group , start date treatment begin . Sputum sample collect cultured every two week thereafter . The date conversion positive negative , subject , date halfway date last culture-positive sputum first culture-negative one . Secondary Endpoints : Bacteriologic secondary endpoint , cell-mediated immune function endpoint BMI .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Antitubercular Agents</mesh_term>
	<criteria>Sputum positive TB patient We exclude abnormal LFTs baseline ( 2.5 time upper limit normal ) , high risk develop druginduced hepatitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>